Skip to content
2000
Volume 19, Issue 3
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Necrotizing enterocolitis (NEC) is a devastating disease that primarily affects the gastrointestinal tract of premature neonates. The diagnosis and treatment of NEC remain challenging. New biomarkers and potential treatments for NEC have emerged in recent years, leading to the potential of earlier therapeutic intervention and improved outcomes. This paper aims to provide a review of the most recent diagnostic indicators and therapeutics of NEC along with a brief overview of future directions of research into this disease.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/1573396318666220805110947
2023-08-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/1573396318666220805110947
Loading

  • Article Type:
    Review Article
Keyword(s): apolipoproteins; biomarkers; necrosis; Necrotizing enterocolitis; neonates; probiotics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test